GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Gross Profit

Gerresheimer AG (XTER:GXI) Gross Profit : €593 Mil (TTM As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Gross Profit?

Gerresheimer AG's gross profit for the three months ended in Feb. 2024 was €130 Mil. Gerresheimer AG's gross profit for the trailing twelve months (TTM) ended in Feb. 2024 was €593 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Gerresheimer AG's gross profit for the three months ended in Feb. 2024 was €130 Mil. Gerresheimer AG's Revenue for the three months ended in Feb. 2024 was €466 Mil. Therefore, Gerresheimer AG's Gross Margin % for the quarter that ended in Feb. 2024 was 27.80%.

Gerresheimer AG had a gross margin of 27.80% for the quarter that ended in Feb. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Gerresheimer AG was 31.39%. The lowest was 19.91%. And the median was 29.90%.


Gerresheimer AG Gross Profit Historical Data

The historical data trend for Gerresheimer AG's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Gross Profit Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 277.19 437.61 446.32 546.81 597.31

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.05 154.12 149.83 159.32 129.59

Competitive Comparison of Gerresheimer AG's Gross Profit

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Gross Profit distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's Gross Profit falls into.



Gerresheimer AG Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Gerresheimer AG's Gross Profit for the fiscal year that ended in Nov. 2023 is calculated as

Gross Profit (A: Nov. 2023 )=Revenue - Cost of Goods Sold
=1990.486 - 1393.172
=597

Gerresheimer AG's Gross Profit for the quarter that ended in Feb. 2024 is calculated as

Gross Profit (Q: Feb. 2024 )=Revenue - Cost of Goods Sold
=466.138 - 336.545
=130

Gross Profit for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €593 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Gerresheimer AG's Gross Margin % for the quarter that ended in Feb. 2024 is calculated as

Gross Margin % (Q: Feb. 2024 )=Gross Profit (Q: Feb. 2024 ) / Revenue (Q: Feb. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=130 / 466.138
=27.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Gerresheimer AG  (XTER:GXI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Gerresheimer AG had a gross margin of 27.80% for the quarter that ended in Feb. 2024 => Competition eroding margins


Gerresheimer AG Gross Profit Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines